Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702))
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
- Ages: Child, adult, older adult
- Sexes: All
- Accepts healthy volunteers?: No
For additional eligibility criteria, please contact the study team.
Contact the study team
Additional eligibility criteria and study procedure details can be explained by the study team. Please call or email:
KeywordsAplastic anemia, Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia, Non-Hodgkin lymphoma, Sickle cell disease
Principal InvestigatorStephanie Lee, MD, MPH
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.